Tumor cells modify TME by producing high levels of VEGF, death ligands (PD-1, FasL, and TRAIL), anti-inflammatory cytokines, and several metabolites such as NO, RNS, and indoleamine 2 3-dioxygenase (IDO) [114]. Here, IDO1 is linked to neoplasm.